Comparative effectiveness and harms of long-acting insulins for type 1 and type 2 diabetes: A systematic review and meta-analysis.

Holmes, Rebecca S; Crabtree, Elizabeth; McDonagh, Marian S

Holmes, Rebecca S; Crabtree, Elizabeth; McDonagh, Marian S.

Affiliation

Holmes RS; Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland, Oregon.
Crabtree E; Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland, Oregon.
McDonagh MS; Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland, Oregon.

Diabetes Obes Metab ; 21(4): 984-992, 2019 04.

Article in En | MEDLINE | ID: mdl-30552792

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 2/drug therapy; Hypoglycemia/chemically induced; Insulin, Long-Acting/therapeutic use; Weight Gain; Blood Glucose/metabolism; Comparative Effectiveness Research; Diabetes Mellitus, Type 1/metabolism; Diabetes Mellitus, Type 2/metabolism; Glycated Hemoglobin/metabolism; Humans; Insulin Detemir/therapeutic use; Insulin Glargine/therapeutic use; Treatment Outcome

Key words

basal insulin; glycaemic control; hypoglycaemia; systematic review; type 1 diabetes; type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Weight Gain / Insulin, Long-Acting / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Hypoglycemia Type of study: Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google